ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells. - Wikidata - wikimedia - TriplyDB

ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.

ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.

http://www.wikidata.org/entity/Q39425033

about

Gene expression changes in initiation and progression of oral squamous cell carcinomas revealed by laser microdissection and oligonucleotide microarray analysis.RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entry Interferon-stimulated gene 15 (ISG15) is a trigger for tumorigenesis and metastasis of hepatocellular carcinoma Novel mode of ISG15-mediated protection against influenza A virus and Sendai virus in mice.Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.Interferon-Stimulated Gene 15 Upregulation Precedes the Development of Blood-Brain Barrier Disruption and Cerebral Edema after Traumatic Brain Injury in Young Mice.Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammation ISG15 deregulates autophagy in genotoxin-treated ataxia telangiectasia cells.Rac-specific guanine nucleotide exchange factor DOCK1 is a critical regulator of HER2-mediated breast cancer metastasis.ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system.ISGylation governs the oncogenic function of Ki-Ras in breast cancer.ISGylation - a key to lock the cell gates for preventing the spread of threats.Roles of miR-138 and ISG15 in oral squamous cell carcinoma.Oncogene-mediated regulation of p53 ISGylation and functions.Cell type-dependent regulation of free ISG15 levels and ISGylation.ISG15: A double edged sword in cancer.DDX5/p68 associated lncRNA LOC284454 is differentially expressed in human cancers and modulates gene expression.ISG15 silencing increases cisplatin resistance via activating p53-mediated cell DNA repair.New and Old Genes Associated with Primary and Established Responses to Cisplatin and Topotecan Treatment in Ovarian Cancer Cell Lines.Mechanism of cell-intrinsic adaptation to Adams-Oliver Syndrome gene DOCK6 disruption highlights ubiquitin-like modifier ISG15 as a regulator of RHO GTPases.BRCA1 Mutation Status and Follicular Fluid Exposure Alters NFκB Signaling and ISGylation in Human Fallopian Tube Epithelial Cells.

P2860

Q34284620-CECF58CE-E260-4CB3-B44C-D11D04117E9C Q34440888-6E72AA2B-823C-413A-B622-E3BC52F8D190 Q34483623-194C5A14-24F2-45F9-A463-F18CEE3F7D7B Q34992604-51200099-4E57-4979-A8D9-EBA341C60DBE Q35740189-DF36D64B-7754-41D4-AD1F-1E6B10EE110D Q35857628-7D634278-0AB7-485E-93A5-B04B308FFA36 Q36305938-5B66FDE6-A639-4AA0-8E8B-8F09B6DA2C37 Q36561981-5826B180-E633-4782-825D-ABB5B0A87E0A Q36820193-D304C631-3046-4A38-A812-D95B61EED485 Q37687572-7E810B85-7C48-4051-A4B3-6CDE124FEFE9 Q39210782-5260E346-FA4F-4242-BA24-F3C481F09DD0 Q40079195-419102D1-9F26-4697-BFE5-7F854A92BE53 Q41672604-0326EEA6-9D69-4A33-98E3-10231B111378 Q41836912-66E49339-B78A-4F21-84BA-559F35910127 Q41865133-D3C51DFD-53E3-4A5A-96D3-B12C2D6DEFE5 Q42038867-DB0E3A92-0530-4152-B192-7DC91365A660 Q46244013-A6DE3A31-B01D-40AD-BD7C-BABD3A863E32 Q47138566-AED86364-BD35-4AB9-9A32-0C2EA1D7214A Q48190854-D0F2FE50-2D1C-4B23-B39E-BCEB9526F02B Q51100814-0B554C58-9782-4B54-8F9D-C07D3D5FEEB6 Q55461779-F357F401-E867-47D8-80E4-4C789101F412

P2860

ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.

http://www.wikidata.org/entity/Q39425033

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

ISG15 disrupts cytoskeletal ar ...... in human breast cancer cells.

@en

ISG15 disrupts cytoskeletal ar ...... in human breast cancer cells.

@nl

type

label

ISG15 disrupts cytoskeletal ar ...... in human breast cancer cells.

@en

ISG15 disrupts cytoskeletal ar ...... in human breast cancer cells.

@nl

prefLabel

ISG15 disrupts cytoskeletal ar ...... in human breast cancer cells.

@en

ISG15 disrupts cytoskeletal ar ...... in human breast cancer cells.

@nl

P1433

Q39425033-5E0FF12B-A8E6-4A8A-86E4-0688D54003AE

P1476

Q39425033-DD2CD0DE-8A84-4EE2-A2A2-DBB6BCC80CB7

P2093

Q39425033-1CEC8A6E-813E-4C1F-9070-7DB0F77731BD

Q39425033-26BA1364-328F-450D-9B84-56562EE35062

Q39425033-30F195B9-037F-49FD-B06B-C615DFF8C75C

Q39425033-3959C2D1-0E44-4ABE-9FE8-7F52D8380131

Q39425033-4E3BF0AD-33E4-4C1F-8B28-797C638F0D28

Q39425033-6F1D7B89-0E02-4672-A33F-8D764BE95AE9

Q39425033-8FFA1FC8-1513-4D44-96C9-CF4C8D6E4CC0

Q39425033-E16F920B-6201-48A3-A081-89101F645170

P2860

Q39425033-05B03652-EFE1-45F0-8E45-67DE7E00913F

Q39425033-10FB24B0-4C6E-42BC-9B09-283DF4F22226

Q39425033-1D52F86A-A567-4AEB-B75B-468102873069

Q39425033-24BDF42F-6B1B-42CB-8940-4F707869FBAF

Q39425033-2CD1824D-F96F-4B12-9879-ECC1BB02D502

Q39425033-2EA7E08C-F106-45EC-B9E0-AC703EEE9126

Q39425033-3BDD3643-41FA-4995-A4BB-F173531BEAA6

Q39425033-42281DC2-1BB1-4A17-9A33-A0C60880C7F7

Q39425033-42717795-7463-4150-8E0E-507B5BC92A74

Q39425033-460DED4E-688C-4D1C-9972-36FE73DB6C84

P304

Q39425033-8E302926-AB58-4D44-97D2-8164EE01BD03

P31

Q39425033-6E6C6009-CA95-4651-B494-2078B67F8389

P356

Q39425033-FD2A7A74-CA79-4ADD-96DD-3EAA69B89222

P433

Q39425033-AD810345-6F00-4867-B675-E1D13166F8B1

P478

Q39425033-76C8C49C-92A4-41F7-97BC-D1908C3EDB6D

P50

Q39425033-8E2E7526-2905-4CEA-B756-3F06491E3C88

Q39425033-BDC8EA5A-C4F0-46A3-B747-EAE060B34398

P577

Q39425033-B24461A1-6989-413C-8C76-E61200E77BDB

P5875

Q39425033-2D9830B4-75FB-4610-97E0-AE2779E3EAF7

P698

Q39425033-7EEAFE16-A285-4D99-BF45-BDBDB4BFBEB6

P921

Q39425033-0B0BC23E-C564-4E43-A0B3-A931C7461BD4

P356

EBM.2011.011236

P1433

Experimental Biology and Medicine

P1476

ISG15 disrupts cytoskeletal ar ...... y in human breast cancer cells

@en

P2093

Arthur L Haas

http://www.w3.org/2001/XMLSchema#string

Jerome W Breslin

http://www.w3.org/2001/XMLSchema#string

Julian Burks

http://www.w3.org/2001/XMLSchema#string

Laurence M Wood

http://www.w3.org/2001/XMLSchema#string

Ryan E Reed

http://www.w3.org/2001/XMLSchema#string

Sally Meiners

http://www.w3.org/2001/XMLSchema#string

Shyamal D Desai

http://www.w3.org/2001/XMLSchema#string

Surendran Sankar

http://www.w3.org/2001/XMLSchema#string

P2860

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer

RNF5, a RING finger protein that regulates cell motility by targeting paxillin ubiquitination and altered localization

ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin

ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity

ISG15 modification of filamin B negatively regulates the type I interferon-induced JNK signalling pathway

UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity

Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein

Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation

Conjugates of ubiquitin cross-reactive protein distribute in a cytoskeletal pattern

Integrin alpha6beta4 controls the expression of genes associated with cell motility, invasion, and metastasis, including S100A4/metastasin

P304

38-49

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1258/EBM.2011.011236

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

237

http://www.w3.org/2001/XMLSchema#string

P50

Ashok K. Pullikuth

P577

2011-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51879037

http://www.w3.org/2001/XMLSchema#string

P698

22185919

http://www.w3.org/2001/XMLSchema#string

P921